Expected earnings - BridgeBio Oncology Therapeutics Inc.
Source: US Earnings Reports
BridgeBio Oncology Therapeutics Inc. (BBOT) is expected to report $-0.61 for Q4 2025
BridgeBio Oncology Therapeutics Inc Com
NASDAQ: BBOT
BBOT Trading
2.34% G/L:
$8.965 Last:
76,733 Volume:
$8.84 Open:
BBOT Latest News
March 18, 2026 04:05:00 pm
BBOT Announces Multiple Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2026
March 06, 2026 10:07:35 am
BBOT Announces Publication in Cancer Discovery Highlighting Preclinical Data Demonstrating BBO-11818 is a Potent and Selective panKRAS Inhibitor
March 05, 2026 04:05:00 pm
BBOT Reports Fourth Quarter and Full Year 2025 Financial Results and Update on Corporate Progress
